Team:EPF-Lausanne/Our Project/TetR mutants

From 2011.igem.org

(Difference between revisions)
Line 1: Line 1:
-
{{:Team:EPF-Lausanne/Templates/TetRtemplate|title=Main}}
+
{{:Team:EPF-Lausanne/Templates/TetRtemplate|title=''In-Vitro'' Characterization}}
After having considered several potential transcription factor candidates, the choice was made to use TetR for our transcription factor development pipeline. TetR has several advantages:  
After having considered several potential transcription factor candidates, the choice was made to use TetR for our transcription factor development pipeline. TetR has several advantages:  

Revision as of 01:02, 22 September 2011